Header cover image

Pakistani (KSE) Pharma Industry Analysis

UpdatedApr 23, 2025
DataAggregated Company Financials
Companies11
  • 7D0.3%
  • 3M-0.7%
  • 1Y146.0%
  • YTD-0.4%

In the last week, the Pharma industry is flat overall, with Highnoon Laboratories standing out by going down 4.4%. The past year has been better, since the industry has gained 146% in that time. Earnings are forecast to grow by 36% annually.

Industry Valuation and Performance

Has the Pakistani Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 23 Apr 2025PK₨499.4bPK₨272.6bPK₨23.2b22.8x21.5x1.8x
Fri, 21 Mar 2025PK₨478.9bPK₨266.0bPK₨20.9b25.1x23x1.8x
Sun, 16 Feb 2025PK₨488.7bPK₨257.1bPK₨19.2b24.4x25.5x1.9x
Tue, 14 Jan 2025PK₨456.9bPK₨257.1bPK₨19.2b22.7x23.9x1.8x
Thu, 12 Dec 2024PK₨466.6bPK₨257.0bPK₨19.0b23x24.5x1.8x
Sat, 09 Nov 2024PK₨360.0bPK₨256.6bPK₨19.0b19.8x18.9x1.4x
Mon, 07 Oct 2024PK₨277.7bPK₨251.2bPK₨12.3b17.1x22.5x1.1x
Wed, 04 Sep 2024PK₨257.3bPK₨252.2bPK₨12.2b16.2x21.1x1x
Fri, 02 Aug 2024PK₨240.4bPK₨243.6bPK₨8.3b16.9x29.1x1x
Sun, 30 Jun 2024PK₨244.7bPK₨243.6bPK₨8.3b16.4x29.6x1x
Tue, 28 May 2024PK₨225.6bPK₨238.2bPK₨7.8b20.1x28.8x0.9x
Thu, 25 Apr 2024PK₨189.4bPK₨228.8bPK₨6.6b37.4x28.8x0.8x
Sat, 23 Mar 2024PK₨167.7bPK₨224.1bPK₨6.3b20.8x26.5x0.7x
Mon, 19 Feb 2024PK₨156.2bPK₨221.2bPK₨6.3b19.3x24.8x0.7x
Wed, 17 Jan 2024PK₨164.8bPK₨221.2bPK₨6.3b20.3x26.2x0.7x
Fri, 15 Dec 2023PK₨173.9bPK₨221.2bPK₨6.3b22x27.7x0.8x
Sun, 12 Nov 2023PK₨149.1bPK₨218.2bPK₨6.2b19.8x24.1x0.7x
Tue, 10 Oct 2023PK₨126.9bPK₨211.7bPK₨6.6b16x19.2x0.6x
Thu, 07 Sep 2023PK₨122.4bPK₨209.3bPK₨8.2b11.8x14.9x0.6x
Sat, 05 Aug 2023PK₨146.0bPK₨205.6bPK₨8.7b13.2x16.7x0.7x
Mon, 03 Jul 2023PK₨127.2bPK₨205.6bPK₨8.7b12.2x14.6x0.6x
Wed, 31 May 2023PK₨133.4bPK₨205.2bPK₨9.3b13.7x14.3x0.6x
Fri, 28 Apr 2023PK₨136.0bPK₨194.2bPK₨13.8b9.4x9.8x0.7x
Sun, 26 Mar 2023PK₨140.7bPK₨191.5bPK₨15.1b9.4x9.3x0.7x
Tue, 21 Feb 2023PK₨144.8bPK₨189.4bPK₨15.2b9.3x9.5x0.8x
Thu, 19 Jan 2023PK₨140.2bPK₨189.4bPK₨15.2b9x9.2x0.7x
Sat, 17 Dec 2022PK₨168.5bPK₨189.4bPK₨15.2b10.6x11.1x0.9x
Mon, 14 Nov 2022PK₨191.3bPK₨187.5bPK₨14.9b12.6x12.8x1x
Wed, 12 Oct 2022PK₨199.2bPK₨180.8bPK₨17.2b11.9x11.6x1.1x
Fri, 09 Sep 2022PK₨201.6bPK₨172.4bPK₨18.5b11.8x10.9x1.2x
Sun, 07 Aug 2022PK₨210.2bPK₨169.3bPK₨21.5b10.2x9.8x1.2x
Tue, 05 Jul 2022PK₨214.3bPK₨167.9bPK₨21.4b10.8x10x1.3x
Thu, 02 Jun 2022PK₨207.4bPK₨163.7bPK₨21.2b9.2x9.8x1.3x
Sat, 30 Apr 2022PK₨222.1bPK₨161.9bPK₨21.1b9.8x10.5x1.4x
Price to Earnings Ratio

10.5x


Total Market Cap: PK₨222.1bTotal Earnings: PK₨21.1bTotal Revenue: PK₨161.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Pharma Industry Price to Earnings3Y Average 18.5x202320242025
Current Industry PE
  • Investors are optimistic on the Pakistani Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 21.5x which is higher than its 3-year average PE of 18.5x.
  • The 3-year average PS ratio of 1.0x is lower than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 3.3% per year over the last three years.
  • Revenues for these companies have grown 19% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Pakistani Healthcare industry?

PK Market0.64%
Healthcare0.36%
Pharma0.27%
Pharma0.27%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AGP AGPPK₨209.587.2%
+PK₨3.9b
153.1%PE22x
GLAXO GlaxoSmithKline PakistanPK₨455.262.3%
+PK₨3.2b
367.7%PE22.2x
ABOT Abbott Laboratories (Pakistan)PK₨1.06k0.7%
+PK₨719.6m
90.8%PE19.8x
BFBIO BF BiosciencesPK₨160.012.9%
+PK₨398.4m
n/aPE33x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CPHL

PK₨92.50

Citi Pharma

7D

-3.9%

1Y

278.2%

GLAXO

PK₨455.26

GlaxoSmithKline Pakistan

7D

2.3%

1Y

367.7%

HINOON

PK₨929.84

Highnoon Laboratories

7D

-4.2%

1Y

69.0%

ABOT

PK₨1,058.94

Abbott Laboratories (Pakistan)

7D

0.7%

1Y

90.8%

AGP

PK₨209.58

AGP

7D

7.2%

1Y

153.1%

HPL

PK₨3,074.48

Hoechst Pakistan

7D

-3.8%

1Y

119.6%

OTSU

PK₨167.85

Otsuka Pakistan

7D

-7.8%

1Y

15.0%

FEROZ

PK₨301.54

Ferozsons Laboratories

7D

-2.1%

1Y

33.5%

SEARL

PK₨93.40

Searle

7D

-0.6%

1Y

65.6%

BFBIO

PK₨160.01

BF Biosciences

7D

2.9%

1Y

n/a

LIVEN

PK₨77.03

Liven Pharmaceuticals

7D

-9.4%

1Y

650.0%